Leap Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy LPTX

*Your capital is at risk

$0.690

+0 (+0%)

At Close: Jun 30, 2026

Currently predicting for Thu, 6 Aug 2026

LPTX Live board

Community Bull/Bear

Target Next close

Join the LPTX prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

LPTX Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For LPTX

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

LPTX Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT LEAP THERAPEUTICS INC.

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and com...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FCX $62.63	7.46%	Jul 31
MC $67.08	2.40%	Jul 31
ARW $212.85	6.96%	Jul 30
BIIB $202.19	3.10%	Jul 24
F FERG $230.67	10.77%	Jul 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by